Clover Health (CLOV) Soars 41% as Analyst Goes “Buy”

Core Insights - Clover Health Investments, Corp. (NASDAQ:CLOV) experienced a significant increase in share prices, rising by 40.96% week-on-week, driven by a "buy" recommendation from Zacks Research [1][2] - The Zacks Consensus Estimate for Clover Health's earnings per share for the fiscal year ending December 2025 is projected to be $0.10, which remains unchanged from the previous year, but estimates have increased by 25% over the past three months [2] Financial Performance - Clover Health is expected to report its third quarter financial results on November 6, 2025 [3] - The upward trend in earnings estimates is a key factor influencing the stock price [1]